Novo Nordisk, the pharmaceutical company behind Ozempic, has launched a national campaign promoting its injectable ...
Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are ...
FAT jabs could be the cancer hope of the future after early studies found they reduce the risk of tumours. The world’s top experts are preparing for a research boom to find out if the wonder drugs ...
In a letter to Bernie Sanders, Novo Nordisk said it only retains 60% of the list price of either Ozempic or Wegovy ...
A recent US study has found that weight loss medications like Wegovy and Ozempic may increase the risk of abdominal paralysis ...
Not only has the Danish economy benefited from the success of Ozempic and Wegovy, two more weight-management medications ...
La liste des vertus potentielles du Wegovy, le médicament anti-obésité de Novo Nordisk, continue de s’allonger. En mars dernier, la Food and Drug administration (FDA) a approuvé son usage ...
The company reported $175.8 million in sales of Zepbound in the first few weeks of its launch in December. The drug, ...
Les actions européennes progressent grâce aux valeurs technologiques à l'approche de la décision de la BCE 06/06 RE Novo Nordisk fait face à la concurrence en Chine pour l'ingrédient clé de ...
Élargir les indications de son Wegovy est crucial pour Novo Nordisk car cela ouvre la voie au remboursement de son médicament. Hollie Adams / REUTERS Le laboratoire danois explore aussi les ...
Les actions européennes progressent grâce aux valeurs technologiques à l'approche de la décision de la BCE 06/06 RE Novo Nordisk fait face à la concurrence en Chine pour l'ingrédient clé de ...